These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22026504)

  • 21. Risk factors of herpes zoster among children immunized with varicella vaccine: results from a nested case-control study.
    Tseng HF; Smith N; Marcy SM; Sy LS; Chao CR; Jacobsen SJ
    Pediatr Infect Dis J; 2010 Mar; 29(3):205-8. PubMed ID: 19952977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prevention of herpes zoster by vaccination].
    Kofoed K; Rønholt F; Gerstoft J; Sand C
    Ugeskr Laeger; 2011 Jan; 173(2):110-4. PubMed ID: 21219841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous vaccination of Chinese applicants for a United States immigrant visa.
    Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F
    Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-marketing safety evaluation of a tetanus toxoid, reduced diphtheria toxoid and 3-component acellular pertussis vaccine administered to a cohort of adolescents in a United States health maintenance organization.
    Klein NP; Hansen J; Lewis E; Lyon L; Nguyen B; Black S; Weston WM; Wu S; Li P; Howe B; Friedland LR
    Pediatr Infect Dis J; 2010 Jul; 29(7):613-7. PubMed ID: 20190673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of vaccination against herpes zoster in adults aged over 60 years in Belgium.
    Bilcke J; Marais C; Ogunjimi B; Willem L; Hens N; Beutels P
    Vaccine; 2012 Jan; 30(3):675-84. PubMed ID: 22120193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herpes zoster vaccine and the incidence of recurrent herpes zoster in an immunocompetent elderly population.
    Tseng HF; Chi M; Smith N; Marcy SM; Sy LS; Jacobsen SJ
    J Infect Dis; 2012 Jul; 206(2):190-6. PubMed ID: 22669900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The safety profile of varicella vaccine: a 10-year review.
    Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
    J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Why should older adults receive the shingles vaccine?
    Harkness TL
    J Gerontol Nurs; 2010 Oct; 36(10):51-5. PubMed ID: 20506935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Vaccine Safety Datalink project.
    DeStefano F;
    Pharmacoepidemiol Drug Saf; 2001; 10(5):403-6. PubMed ID: 11802585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contacts with children and young people and adult risk of suffering herpes zoster.
    Salleras M; Domínguez A; Soldevila N; Prat A; Garrido P; Torner N; Borrás E; Salleras L
    Vaccine; 2011 Oct; 29(44):7602-5. PubMed ID: 21889558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of herpes zoster vaccination among inflammatory bowel disease patients being treated with anti-TNF medications.
    Khan N; Shah Y; Trivedi C; Lewis JD
    Aliment Pharmacol Ther; 2017 Oct; 46(7):668-672. PubMed ID: 28805309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of association between acellular pertussis vaccine and seizures in early childhood.
    Huang WT; Gargiullo PM; Broder KR; Weintraub ES; Iskander JK; Klein NP; Baggs JM;
    Pediatrics; 2010 Aug; 126(2):263-9. PubMed ID: 20643726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using the Self-Controlled Tree-Temporal Scan Statistic to Assess the Safety of Live Attenuated Herpes Zoster Vaccine.
    Yih WK; Kulldorff M; Dashevsky I; Maro JC
    Am J Epidemiol; 2019 Jul; 188(7):1383-1388. PubMed ID: 31062840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on herpes zoster vaccine: licensure for persons aged 50 through 59 years.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Nov; 60(44):1528. PubMed ID: 22071592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe Autoimmune Adverse Events Post Herpes Zoster Vaccine: A Case-Control Study of Adverse Events in a National Database.
    Lai YC; Yew YW
    J Drugs Dermatol; 2015 Jul; 14(7):681-4. PubMed ID: 26151783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-time vaccine safety surveillance for the early detection of adverse events.
    Lieu TA; Kulldorff M; Davis RL; Lewis EM; Weintraub E; Yih K; Yin R; Brown JS; Platt R;
    Med Care; 2007 Oct; 45(10 Supl 2):S89-95. PubMed ID: 17909389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and immunogenicity profile of the concomitant administration of ZOSTAVAX and inactivated influenza vaccine in adults aged 50 and older.
    Kerzner B; Murray AV; Cheng E; Ifle R; Harvey PR; Tomlinson M; Barben JL; Rarrick K; Stek JE; Chung MO; Schödel FP; Wang WW; Xu J; Chan IS; Silber JL; Schlienger K
    J Am Geriatr Soc; 2007 Oct; 55(10):1499-507. PubMed ID: 17908055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.
    Betts RF
    J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S143-7. PubMed ID: 18021866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Family history and herpes zoster risk in the era of shingles vaccination.
    Hernandez PO; Javed S; Mendoza N; Lapolla W; Hicks LD; Tyring SK
    J Clin Virol; 2011 Dec; 52(4):344-8. PubMed ID: 21924676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.